XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
 [1]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
 [1]
Cumulative Effect, Period of Adoption, Adjustment [Member]
 [1]
Cash Dividend [Member]
Retained Earnings [Member]
Cash Dividend [Member]
Common Stock Including Additional Paid in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2017           3,448,569      
Balance at Dec. 31, 2017 $ 244 $ (244) $ 0     $ 50,290 $ 26,023 $ 237 $ 76,550
Net income             7,333   7,333
Other comprehensive income (loss)               (725) (725)
Shares issued (in shares)           7,904      
Shares issued           $ 126     126
Shares repurchased (in shares)           (20,628)      
Shares repurchased           $ (523)     (523)
Effect of employee stock purchases           $ 13     13
Stock options exercised and issued (in shares) [2]           1,241      
Stock options exercised and issued [2]                 0
Stock-based compensation expense           $ 282     282
Restricted stock units issued (in shares)           7,303      
Stock dividend declared (5%) (in shares)           172,094      
Stock dividend declared (5%)           $ 4,335 (4,342)   (7)
Cash dividends declared [3]       $ (2,572) $ (2,572)        
Balance (in shares) at Dec. 31, 2018           3,616,483      
Balance at Dec. 31, 2018           $ 54,523 26,686 (732) 80,477
Net income             7,171   7,171
Other comprehensive income (loss)               2,210 2,210
Shares issued (in shares)           8,118      
Shares issued           $ 25     25
Shares repurchased (in shares)           (2,228)      
Shares repurchased           $ (67)     (67)
Effect of employee stock purchases           $ 14     14
Stock options exercised and issued (in shares) [2]           3,913      
Stock options exercised and issued [2]           $ 78     78
Stock-based compensation expense           $ 398     398
Cash dividends declared             (5,806)   (5,806)
Restricted stock units issued                 0
Merger, net of issuance costs (in shares)           3,603,872      
Merger, net of issuance costs           $ 107,639     $ 107,639
Balance (in shares) at Dec. 31, 2019           7,245,088     7,245,088
Balance at Dec. 31, 2019           $ 162,610 28,051 1,478 $ 192,139
Net income             15,613   15,613
Other comprehensive income (loss)               9,550 9,550
Shares issued (in shares)           19,583      
Shares issued           $ 451     451
Effect of employee stock purchases           $ 24     $ 24
Stock options exercised and issued (in shares)           7,261     35,617
Stock options exercised and issued                 $ 0
Restricted stock units issued (in shares)           365      
Cash dividends declared             (6,174)   (6,174)
Restricted stock units issued                 0
Merger, net of issuance costs (in shares)           524,055      
Merger, net of issuance costs           $ 15,494     15,494
Stock-based compensation expense           $ 171     $ 171
Balance (in shares) at Dec. 31, 2020           7,796,352     7,796,352
Balance at Dec. 31, 2020           $ 178,750 $ 37,490 $ 11,028 $ 227,268
[1] ASU 2016-01 is further addressed in Note 1 to the financial statements.
[2] The amount shown represents the number of shares issued in cashless transactions where some taxes are netted on a portion of the exercises.
[3] Adjusted for 5% stock dividend issued on May 31, 2018.